Stella E Tsirka Selected Research

Breast Neoplasms (Breast Cancer)

1/2022

Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stella E Tsirka Research Topics

Disease

13	Glioma (Gliomas) 01/2024 - 10/2011
10	Neoplasms (Cancer) 01/2024 - 03/2011
9	Inflammation (Inflammations) 09/2022 - 04/2003
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2020 - 12/2002
6	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 01/2008
6	Stroke (Strokes) 07/2012 - 04/2002
5	Seizures (Absence Seizure) 01/2022 - 02/2006
5	Demyelinating Diseases (Demyelinating Disease) 11/2020 - 12/2002
4	Ischemic Stroke 10/2023 - 01/2005
4	Disease Progression 01/2014 - 08/2009
4	Cerebral Hemorrhage 07/2012 - 11/2003
3	Epilepsy (Aura) 01/2022 - 04/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 01/2022
2	Neuroinflammatory Diseases 09/2022 - 01/2022
2	Hemorrhage 02/2014 - 03/2005
2	Gliosis 10/2011 - 01/2008
2	Brain Injuries (Brain Injury) 05/2007 - 07/2005
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2023
1	Infections 09/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Mental Disorders (Mental Disorder) 10/2020
1	Contusions 01/2019
1	Paralysis (Palsy) 01/2018
1	Spinal Cord Diseases 01/2018
1	Weight Gain 01/2018
1	Nervous System Diseases (Neurological Disorders) 04/2015
1	Body Weight (Weight, Body) 01/2014
1	Anthracosis 10/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Necrosis 06/2012
1	Hematoma 05/2012

Drug/Important Bio-Agent (IBA)

9	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2011 - 04/2002
6	Neuropilin-1IBA 01/2022 - 03/2016
6	TuftsinIBA 01/2018 - 11/2003
6	Fibrinolysin FDA Link 01/2012 - 04/2002
5	Serine Proteases (Serine Protease)IBA 10/2007 - 04/2002
4	CytokinesIBA 01/2018 - 01/2012
4	Peptide Hydrolases (Proteases)FDA Link 01/2012 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2012
3	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 11/2018 - 03/2016
3	ChemokinesIBA 02/2014 - 12/2002
3	threonyl-lysyl-proline (TKP)IBA 09/2012 - 03/2005
3	Neuroprotective AgentsIBA 03/2005 - 11/2003
2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 01/2022
2	LucanthoneIBA 01/2024 - 01/2022
2	Kainic Acid (Kainate)IBA 01/2022 - 04/2003
2	Immune Checkpoint InhibitorsIBA 01/2021 - 05/2020
2	CuprizoneIBA 11/2020 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2019 - 07/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2016 - 04/2012
2	Collagenases (Collagenase)FDA Link 05/2012 - 11/2003
2	Chondroitinases and Chondroitin LyasesIBA 10/2011 - 01/2008
2	NeurotoxinsIBA 05/2007 - 04/2002
1	palmitoyl-protein thioesteraseIBA 01/2024
1	Nerve Growth Factors (Neurotrophins)IBA 09/2022
1	Dronabinol (THC)FDA LinkGeneric 09/2022
1	MicroRNAs (MicroRNA)IBA 09/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	CannabidiolIBA 01/2022
1	Histones (Histone)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 11/2020
1	Guanabenz (BR 750)FDA Link 11/2020
1	Immunologic Factors (Immunomodulators)IBA 10/2020
1	pifithrinIBA 01/2019
1	Conditioned Culture MediaIBA 10/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	PLX5622IBA 01/2018
1	Benztropine (Benzatropine)FDA LinkGeneric 01/2018
1	Cell Surface ReceptorsIBA 01/2018
1	Ramipril (Altace)FDA LinkGeneric 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016
1	NitritesIBA 05/2016
1	InterleukinsIBA 05/2016
1	EndocannabinoidsIBA 04/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2014
1	Nicotine FDA Link 01/2014
1	SmokeIBA 01/2014
1	Coal (Coals)IBA 10/2013
1	pyriteIBA 10/2013
1	HMGB2 ProteinIBA 01/2013
1	Laminin (Merosin)IBA 07/2012
1	ProstaglandinsIBA 07/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2012
1	Cyclophilins (Cyclophilin)IBA 06/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2012
1	Mitochondrial Permeability Transition PoreIBA 06/2012
1	MineralsIBA 04/2012

Therapy/Procedure

12	Therapeutics 01/2024 - 02/2008
2	Radiotherapy 01/2021 - 05/2020
1	Drug Therapy (Chemotherapy) 01/2024
1	Thrombectomy 10/2023
1	Combined Modality Therapy 01/2022
1	Pain Management 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Cranial Irradiation 01/2021
1	Immunomodulation 11/2020
1	Immunotherapy 04/2018